
Global Home Blood Testing Devices Market Report and Forecast 2024-2032
Description
Global Home Blood Testing Devices Market Report and Forecast 2024-2032
Global Home Blood Testing Devices Market Report and Forecast 2024-2032
Global Home Blood Testing Devices Market Outlook
The global home blood testing devices market size was valued at USD 16.4 billion in 2023, driven by increasing prevalence of chronic diseases like diabetes. The market size is anticipated to grow at a CAGR of 10.7% during the forecast period of 2024-2032 to achieve a value of USD 41.1 billion by 2032.
Home Blood Testing Devices: Introduction
Home blood testing devices are compact, user-friendly tools that allow individuals to monitor various health parameters by analyzing small blood samples. Commonly used for checking blood glucose levels in diabetics, coagulation rates in those on anticoagulants, or lipid profiles for cardiovascular health, these devices offer convenience, privacy, and immediate results. They play a crucial role in self-managing chronic conditions, promoting proactive health management, and reducing the need for frequent clinical visits.
Key Trends in the Global Home Blood Testing Devices Market
The rising prevalence of chronic diseases like diabetes is a major driving force behind the growth of the home blood testing devices market. This increase in chronic health conditions is leading to a higher demand for home-based monitoring and testing solutions.
Advances in technology are playing a crucial role in the market's expansion. Innovations in blood testing devices are making them more user-friendly, accurate, and efficient, thus encouraging their adoption among consumers.
The convenience of being able to monitor one's health from the comfort of home is a significant factor in the market's growth. Home blood testing devices offer a convenient alternative to traditional laboratory testing, saving time and making regular monitoring more accessible for patients with chronic conditions.
There's a growing trend of health consciousness among consumers. More people are taking proactive steps towards managing their health, which includes regular monitoring of vital health parameters through home blood testing devices.
Regulatory bodies are increasingly recognizing the importance of home-based health monitoring solutions. This recognition is leading to more supportive policies and guidelines, which in turn is encouraging the development and adoption of home blood testing devices.
Home blood testing devices are increasingly being integrated with digital health platforms, allowing for better data management, analysis, and remote consultation with healthcare professionals. This integration enhances the utility and effectiveness of home blood testing, contributing to market growth.
Global Home Blood Testing Devices Market Segmentation
Market Breakup by Type
- Glucose Test Kits
- Infectious Diseases Test Kits
- Cholesterol Test Strips
- Drugs of Abuse Test Kits
- Coagulation Monitoring Tests
- Others
- Pediatric
- Adult
- Geriatric
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
In North America, the market for home blood testing devices is highly developed, driven by a growing prevalence of chronic diseases like diabetes and cardiovascular conditions. The United States leads with a high adoption rate of digital health technologies and a strong emphasis on preventive healthcare. Consumers in this region are well-informed and proactive about health monitoring, supported by advanced healthcare infrastructure and widespread availability of sophisticated home testing devices.
Europe presents a mature market for home blood testing devices, characterized by high healthcare standards and a significant focus on home healthcare solutions. Countries such as Germany, the UK, and France are at the forefront, propelled by an aging population, increased prevalence of chronic diseases, and a strong healthcare system. The market is also supported by favorable government initiatives aimed at reducing hospital visits and promoting self-care practices.
The Asia-Pacific region is witnessing rapid growth in the home blood testing devices market. Factors such as rising healthcare awareness, increasing disposable incomes, and a burgeoning middle class contribute to this growth. Countries like China, India, and Japan are experiencing a surge in demand for home healthcare solutions, driven by a growing elderly population, urbanization, and improvements in healthcare infrastructure. However, the market faces challenges such as disparities in healthcare access and awareness.
Global Home Blood Testing Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- ACON Laboratories Inc
- Quidel Corporation
- OraSure Technologies Inc
- Cardinal Health Inc
- PHC Holdings Corporation
- B. Braun Melsungen AG
- Abbott Laboratories
- Biomerieux SA
- F. Hoffmann-La-Roche Ltd
- Everly Health Inc
- Walgreens
- D&A health
- Pts Disgnostics
- Trinity Biotech Plc
- Siemens Healthineers
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
160 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Home Blood Testing Devices Market Overview
- 3.1 Global Home Blood Testing Devices Market Historical Value (2017-2023)
- 3.2 Global Home Blood Testing Devices Market Forecast Value (2024-2032)
- 4 Global Home Blood Testing Devices Market Landscape
- 4.1 Global Home Blood Testing Devices Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Home Blood Testing Devices Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Home Blood Testing Devices Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Home Blood Testing Devices Market Segmentation
- 6.1 Global Home Blood Testing Devices Market by Type
- 6.1.1 Market Overview
- 6.1.2 Glucose Test Kits
- 6.1.3 Infectious Diseases Test Kits
- 6.1.4 Cholesterol Test Strips
- 6.1.5 Drugs of Abuse Test Kits
- 6.1.6 Coagulation Monitoring Tests
- 6.1.7 Others
- 6.2 Global Home Blood Testing Devices Market by Age Group
- 6.2.1 Market Overview
- 6.2.2 Pediatric
- 6.2.3 Adult
- 6.2.4 Geriatric
- 6.3 Global Home Blood Testing Devices Market by Distribution Channel
- 6.3.1 Market Overview
- 6.3.2 Hospital Pharmacy
- 6.3.3 Retail Pharmacy
- 6.3.4 Online Pharmacy
- 6.3.5 Others
- 6.4 Global Home Blood Testing Devices Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America Home Blood Testing Devices Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Home Blood Testing Devices Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Home Blood Testing Devices Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Home Blood Testing Devices Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Home Blood Testing Devices Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 ACON Laboratories Inc
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Quidel Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 OraSure Technologies Inc
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Cardinal Health Inc
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 PHC Holdings Corporation
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 B. Braun Melsungen AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Abbott Laboratories
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Biomerieux SA
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 F. Hoffmann-La-Roche Ltd
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Everly Health Inc
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Walgreens
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 D&A health
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Pts Disgnostics
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Trinity Biotech Plc
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Siemens Healthineers
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 18 Global Home Blood Testing Devices Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.